EGFR-TKI-naïve Patients With NSCLC Harboring EGFR Activating Mutations
Drug | Drug Name | Drug Description |
---|
Drug | Drug Name | Target | Type |
---|
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB12036 | Naquotinib | 2 | Terminated | 1 |
Drug | Drug Name | Drug Description |
---|
Drug | Drug Name | Target | Type |
---|
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB12036 | Naquotinib | 2 | Terminated | 1 |